Comerica Bank’s Cabaletta Bio CABA Stock Holding History

Comerica Bank’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-41,599	Closed	-$57.6K	–	3705
2025 Q1	$57.6K	Buy	41,599 +39,860	+2,292%	+$84.9K	﹤0.01%	2747
2024 Q4	$3.95K	Buy	1,739 +1,447	+496%	+$5.08K	﹤0.01%	3361
2024 Q3	$1.38K	Sell	292 -705	-71%	-$4.08K	﹤0.01%	3542
2024 Q2	$7.46K	Sell	997 -958	-49%	-$11.7K	﹤0.01%	3224
2024 Q1	$33.4K	Buy	1,955 +12	+0.6%	+$258	﹤0.01%	2877
2023 Q4	$44.1K	Sell	1,943 -85	-4%	-$1.43K	﹤0.01%	2763
2023 Q3	$30.9K	Buy	+2,028	New	+$27.7K	﹤0.01%	2853

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Comerica Bank's CABA Position: Q2 2025 in Review

Comerica Bank sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 41,599 shares — an estimated $57.6K sold.

Comerica Bank first reported a position in CABA in Q3 2023 and held it in 7 quarters. The position peaked at $57.6K in Q1 2025. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

Comerica Bank reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
Comerica Bank sold 41,599 Cabaletta Bio shares in Q2 2025, an estimated $57.6K.
Comerica Bank first reported a position in Cabaletta Bio in Q3 2023 and held it in 7 quarters.
Comerica Bank's Cabaletta Bio position peaked at $57.6K in Q1 2025.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.